Table 4 The effect of treatment on markers of lipid profile, hepatic enzymes, and fasting blood sugar of burn patients during the interventiona
Variables | Group A ISP + FO (n = 25) | Group B ISP + CO (n = 24) | Group C Control (n = 24) | P value |
|---|---|---|---|---|
FBSb (mg/dL) | 1.93 ± 1.55c (0.0 to 3.8) | 3.15 ± 1.44c (0.85 to 5.44) | 3.28 ± 0.71c (2.54 to 4.03) | 0.58 |
TG (mg/dL) | −30.04 ± 64.40c (− 59.36 to − 0.73) | −3.28 ± 84.76c (− 41.86 to 35.29) | 1.58 ± 59.84c (− 23.68 to 26.85) | 0.28 |
Total cholesterol (mg/dL) | −44.38 ± 27.93c (− 57.09 to − 31.66) | −26.19 ± 48.44c (− 48.24 to − 4.13) | − 13.75 ± 51.80c (− 35.62 to 8.12) | 0.07 |
ALTb (IU/L) | 3.42 ± 1.09c (2.79 to 4.05) | 3.27 ± 1.47c (2.45 to 4.08) | 3.25 ± 0.83c (2.86 to 3.64) | 0.84 |
ASTb (IU/L) | 2.49 ± 1.26c (1.51 to 3.46) | 3.23 ± 0.84c (2.69 to 3.77) | 3.24 ± 1.18c (2.48 to 3.99) | 0.16 |
ALP (IU/L) | 57.76 ± 15.88c (24.63 to 90.8) | 56.17 ± 25.06c (30.87 to 90.46) | 63.70 ± 12.80c (37.22 to 90.19) | 0.95 |
Total protein (g/dL) | + 0.91 ± 0.22c (0.45 to 1.38) | + 0.89 ± 0.25c (0.37 to 1.4) | + 0.74 ± 0.27c (0.18 to 1.3) | 0.86 |
Total bilirubinb (mg/dL) | −2.57 ± 0.70c (− 3.31 to − 1.83) | −2.76 ± 0.52c (− 3.40 to − 2.11) | −2.93 ± 0.55c (− 3.40 to 2.11) | 0.10 |
Direct bilirubinb (mg/dL) | −2.04 ± 0.22c (− 2.14 to − 1.93) | −2.04 ± 0.20c (− 2.14 to − 1.95) | −2.07 ± 0.19c (− 2.15 to − 1.99) | 0.75 |